Categories: News

Bybit Kazakhstan and AFSA Pioneer Stablecoin Payments for AIFC Regulatory Fees

ASTANA, Kazakhstan, Sept. 5, 2025 /PRNewswire/ — Bybit Kazakhstan (Bybit Limited), a subsidiary of Bybit – the world’s second-largest cryptocurrency exchange by trading volume, today announced a strategic collaboration with the Astana Financial Services Authority (AFSA) to enable participants of the Astana International Financial Centre (AIFC) to pay regulatory fees using U.S. dollar–pegged stablecoins.

- Advertisement -

This initiative follows AFSA’s announcement of a pioneering framework that allows licensed digital asset service providers to act as agents for settling regulatory fees via stablecoins. Bybit Limited proudly became the first signatory of the multilateral memorandum of understanding (MMoU), underscoring the exchange’s trusted status as a compliant, innovative partner in Kazakhstan’s rapidly evolving digital finance ecosystem.

- Advertisement -

The agreement, announced during the Astana Finance Days conference, expands the AIFC’s payment ecosystem. Under the agreement, Bybit Kazakhstan will provide AFSA with a customized Bybit QR Pay solution and a dedicated stablecoin wallet for invoicing, offering both efficiency and transparency in the process.

- Advertisement -

Mazurka Zeng, Chief Operating Officer at Bybit said, “Bybit Kazakhstan is honored to stand alongside AFSA in shaping a regulatory-first model for stablecoin adoption. As the first MMoU signatory, we see this as a strategic milestone that reflects both AFSA’s forward-looking vision and the trust placed in Bybit to deliver compliant, secure, and frictionless payment solutions. Together, we are building an infrastructure that empowers entrepreneurs, consumers, and businesses to capture borderless opportunities in the stablecoin-powered financial future.”

- Advertisement -

AFSA Chief Executive Officer Evgeniya Bogdanova commented, “Stablecoins are reshaping global finance, and by accepting regulatory fees in USD-pegged stablecoins we make the AIFC faster, more open, and firmly connected to the future — offering participants a modern, reliable way to grow within a trusted regulatory framework.”

- Advertisement -

This partnership reinforces Kazakhstan’s role as a frontrunner in regulated digital finance and showcases Bybit’s commitment to supporting compliant innovation that bridges traditional finance and the digital asset economy.

- Advertisement -

#Bybit / #TheCryptoArk / #BybitKazakhstan

- Advertisement -

About Bybit Kazakhstan (Bybit Limited)
Bybit Kazakhstan is an AIFC Participant licensed by AFSA to operate a Digital Asset Trading Facility and provide Money Services in relation to Digital Assets. Bybit Kazakhstan develops compliant infrastructure to support institutions and enterprises engaging with digital assets in Kazakhstan.
www.bybit.kz 

- Advertisement -

Media contact: media@bybit.com

- Advertisement -

About AFSA
The Astana Financial Services Authority (AFSA) is the independent regulator of financial services and related activities in the AIFC. AFSA’s mandate is to foster a fair, transparent and efficient financial centre aligned with international standards.
www.afsa.kz

- Advertisement -

Photo – https://mma.prnewswire.com/media/2765257/From_left_Evgeniya_Bogdanova_AFSA_Chief_Executive_Officer_Mazurka_Zeng.jpg
Logo – https://mma.prnewswire.com/media/2765456/Bybit_Kazakhstan_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/bybit-kazakhstan-and-afsa-pioneer-stablecoin-payments-for-aifc-regulatory-fees-302547534.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

13 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

17 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

17 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

17 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

17 hours ago